bucladesine has been researched along with Leukemia, T-Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assaraf, YG; Rothem, L; Stark, M | 1 |
| Barrera-Rodríguez, R; Cerezo-Roman, J; Fernández-Mejia, C; Madrid-Marina, V; Martínez-Valdez, H; Navarro-Duque, C; Peralta-Zaragoza, O | 1 |
| Akutagawa, H; Mayumi, M; Mikawa, H; Morita, M; Nambu, M; Ohshima, Y; Uenoyama, Y | 1 |
| An, S; Goetzl, EJ; Zeng, L | 1 |
| Epstein, PM; Jiang, X; Paskind, M; Weltzien, R | 1 |
5 other study(ies) available for bucladesine and Leukemia, T-Cell
| Article | Year |
|---|---|
Impaired CREB-1 phosphorylation in antifolate-resistant cell lines with down-regulation of the reduced folate carrier gene.
Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Carrier Proteins; Cell Line, Tumor; Colforsin; Cyclic AMP Response Element-Binding Protein; Cyclophosphamide; Down-Regulation; Drug Resistance, Neoplasm; Folate Receptors, GPI-Anchored; Folic Acid Antagonists; Humans; Leukemia, T-Cell; Phosphorylation; Receptors, Cell Surface; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transfection | 2004 |
Regulation of gene expression of adenosine deaminase, purine nucleoside phosphorylase and terminal deoxynucleotidyl transferase by dexamethasone and cAMP in human leukemic cells.
Topics: Adenosine Deaminase; Bucladesine; Cell Line; Cyclic AMP; Dexamethasone; DNA Nucleotidylexotransferase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, B-Cell; Leukemia, T-Cell; Purine-Nucleoside Phosphorylase; Time Factors; Tumor Cells, Cultured | 1994 |
Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1.
Topics: Actins; Blood Proteins; Bucladesine; Calcimycin; Calcium-Transporting ATPases; Cell Differentiation; Culture Media; Dose-Response Relationship, Drug; Eosinophil Granule Proteins; Eosinophils; Humans; Hypersensitivity; Immunoglobulin G; Inflammation; Leukemia, Eosinophilic, Acute; Leukemia, T-Cell; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Phthalazines; Platelet Activating Factor; Polymers; Ribonucleases; Tumor Cells, Cultured | 1993 |
Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
Topics: Adenine; Alprostadil; Blotting, Northern; Bucladesine; Calcium; Cell Line; Colforsin; Collagenases; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, T-Cell; Matrix Metalloproteinase 9; Misoprostol; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; RNA, Messenger; T-Lymphocytes; Thapsigargin; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; B-Lymphocytes; Bucladesine; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Leukemia, T-Cell; Lymphocyte Activation; Lymphocytes; Mitogens; Phosphodiesterase Inhibitors; Phytohemagglutinins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Messenger; T-Lymphocytes; Tumor Cells, Cultured | 1998 |